Loading clinical trials...
Loading clinical trials...
Purpose is to evaluate Rheopheresis for the treatment of patients with high-risk dry age-related macular degeneration and no therapeutic alternative. Rheopheresis is a method of therapeutic apheresis ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Apheresis Research Institute
NCT01674829 · Dry Age Related Macular Degeneration
NCT00541333 · Dry Age Related Macular Degeneration
NCT00804102 · Retinitis Pigmentosa, Macula Off, and more
NCT00429936 · Geographic Atrophy, Dry Age Related Macular Degeneration
University of Frankfurt Department of Ophthalmology
Frankfurt
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions